Prokinetisin 1 preeklampsi belirteci olarak kullanılabilir mi?
- 30 September 2022
- journal article
- research article
- Published by Ministry of Health, Ankara City Hospital in Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi
- Vol. 19 (3) , 1368-1372
Abstract
Can prokineticin 1 be used as a biomarker in preeclampsia? Aim: Prokineticins are a group of peptides which play important roles in angiogenesis, hematopoiesis and reproduction. Prokineticin 1 (PROK1) is reported to be the major subgroup affecting the female reproductive development. PROK1 is secreted from the syncytiotrophoblasts and it prevents extravillous trophoblastic cell migration in the first trimester which predispose to the abnormal placentation and preeclampsia (PE). Hypoxia provokes the expression of PROK1 therefore its serum levels increase in pregnants with PE. The aim of the present study was to reveal the value of PROK1 as a marker of PE. Materials and Method: A total of 84 pregnant women were admitted to the study, and 43 of them were diagnosed with preeclampsia. 41 healthy pregnant women were included in the control group. The preeclampsia group was divided into two subgroups as mild PE (n=27) and severe PE (n=16). About 10 ml of venous blood was collected from each participant and dispensed into lithium heparin, and serum was obtained, which were stored at – 80 c until analyzed. Serum PROK1 measurements were performed by using an enzyme-linked immunosorbent assay (ELİSA). All tests were two-tailed, and pKeywords
This publication has 19 references indexed in Scilit:
- EG-VEGF: a key endocrine factor in placental developmentTrends in Endocrinology & Metabolism, 2012
- Revisiting the role of hCG: new regulation of the angiogenic factor EG-VEGF and its receptorsCellular and Molecular Life Sciences, 2011
- Molecular Characterization of EG-VEGF-mediated Angiogenesis: Differential Effects on Microvascular and Macrovascular Endothelial CellsMolecular Biology of the Cell, 2010
- Natural Selection of Human Embryos: Impaired Decidualization of Endometrium Disables Embryo-Maternal Interactions and Causes Recurrent Pregnancy LossPLOS ONE, 2010
- Effects of rosiglitazone on ovarian function and fertility in animals with reduced fertility following fetal and neonatal exposure to nicotineEndocrine, 2009
- Role of EG‐VEGF in human placentation: Physiological and pathological implicationsJournal of Cellular and Molecular Medicine, 2008
- Prokineticin-1 (Prok-1) works coordinately with glial cell line-derived neurotrophic factor (GDNF) to mediate proliferation and differentiation of enteric neural crest cellsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2008
- Placental Expression of EG-VEGF and its Receptors PKR1 (Prokineticin Receptor-1) and PKR2 Throughout Mouse GestationPlacenta, 2007
- Pre-eclampsiaThe Lancet, 2005
- EG-VEGF and the concept of tissue-specific angiogenic growth factorsSeminars in Cell & Developmental Biology, 2002